{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T19:11:59Z","timestamp":1780686719844,"version":"3.54.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,20]],"date-time":"2023-04-20T00:00:00Z","timestamp":1681948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["PA1751\/10-1"],"award-info":[{"award-number":["PA1751\/10-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","award":["H2020-MSCA-ITN-2017-765441"],"award-info":[{"award-number":["H2020-MSCA-ITN-2017-765441"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ejpb.2023.04.012","type":"journal-article","created":{"date-parts":[[2023,4,22]],"date-time":"2023-04-22T20:13:04Z","timestamp":1682194384000},"page":"175-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Ocular permeability, intraocular biodistribution of lipid nanocapsule formulation intended for retinal drug delivery"],"prefix":"10.1016","volume":"187","author":[{"given":"Gustav","family":"Christensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dileep","family":"Urimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lorenzo\u2010Soler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaas","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Paquet-Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ejpb.2023.04.012_b0005","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1038\/cddis.2013.12","article-title":"Retinitis pigmentosa: rapid neurodegeneration is governed by slow cell death mechanisms","volume":"4","author":"Sahaboglu","year":"2013","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.ejpb.2023.04.012_b0010","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/j.1471-4159.2008.05822.x","article-title":"PKG activity causes photoreceptor cell death in two retinitis pigmentosa models","volume":"108","author":"Paquet-Durand","year":"2009","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.ejpb.2023.04.012_b0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12035-008-8045-9","article-title":"Photoreceptor cell death mechanisms in inherited retinal degeneration","volume":"38","author":"Sancho-Pelluz","year":"2008","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ejpb.2023.04.012_b0020","doi-asserted-by":"crossref","unstructured":"L. Liu, X. Liu, Roles of Drug Transporters in Blood-Retinal Barrier, in Drug Transporters in Drug Disposition, Effects and Toxicity, X. Liu and G. Pan, Editors. 2019, Springer Singapore, Singapore. p. 467-504.","DOI":"10.1007\/978-981-13-7647-4_10"},{"issue":"4162","key":"10.1016\/j.ejpb.2023.04.012_b0025","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1126\/science.186.4162.449","article-title":"Cyclic guanosine monophosphate: elevation in degenerating photoreceptor cells of the C3H mouse retina","volume":"186","author":"Farber","year":"1974","journal-title":"Science"},{"key":"10.1016\/j.ejpb.2023.04.012_b0030","doi-asserted-by":"crossref","unstructured":"E. Vighi et al., Combination of cGMP analogue and drug delivery system provides functional protection in hereditary retinal degeneration. Proc. National Acad. Sci. 115(13) (2018) E2997-E3006.","DOI":"10.1073\/pnas.1718792115"},{"key":"10.1016\/j.ejpb.2023.04.012_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120640","article-title":"Formulation development and upscaling of lipid nanocapsules as a drug delivery system for a novel cyclic GMP analogue intended for retinal drug delivery","volume":"602","author":"Urimi","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ejpb.2023.04.012_b0040","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1021\/acs.molpharmaceut.1c00648","article-title":"Structural characterization study of a lipid nanocapsule formulation intended for drug delivery applications using small-angle scattering techniques","volume":"19","author":"Urimi","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2023.04.012_b0045","first-page":"101","article-title":"Preparation, characterization, and in vitro release study of albendazole-encapsulated nanosize liposomes","volume":"5","author":"Panwar","year":"2010","journal-title":"Int. J. Nanomed."},{"issue":"3","key":"10.1016\/j.ejpb.2023.04.012_b0050","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3892\/etm.2015.2201","article-title":"Preparation of a liposomal delivery system and its in vitro release of rapamycin","volume":"9","author":"Miao","year":"2015","journal-title":"Exp. Ther. Med."},{"issue":"9","key":"10.1016\/j.ejpb.2023.04.012_b0055","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1080\/17425247.2020.1783236","article-title":"Ultra-small-size Astragaloside-IV loaded lipid nanocapsules eye drops for the effective management of dry age-related macular degeneration","volume":"17","author":"Sun","year":"2020","journal-title":"Exp. Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2023.04.012_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2020.111398","article-title":"Novel hybrid lipid nanocapsules loaded with a therapeutic monoclonal antibody\u2013Bevacizumab\u2013and Triamcinolone acetonide for combined therapy in neovascular ocular pathologies","volume":"119","author":"Formica","year":"2021","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ejpb.2023.04.012_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118795","article-title":"Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications","volume":"573","author":"Formica","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"Suppl 1","key":"10.1016\/j.ejpb.2023.04.012_b0070","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/S0039-6257(02)00326-0","article-title":"Drug delivery to the posterior segment from drops","volume":"47","author":"Maurice","year":"2002","journal-title":"Surv. Ophthalmol."},{"issue":"2","key":"10.1016\/j.ejpb.2023.04.012_b0075","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jconrel.2012.01.019","article-title":"Liposomes for intravitreal drug delivery: a state of the art","volume":"161","author":"Bochot","year":"2012","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.ejpb.2023.04.012_b0080","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics11080365","article-title":"Pharmacokinetics of intravitreal anti-vegf drugs in age-related macular degeneration","volume":"11","author":"Garc\u00eda-Quintanilla","year":"2019","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.ejpb.2023.04.012_b0085","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13071013","article-title":"Investigating ex vivo animal models to test the performance of intravitreal liposomal drug delivery systems","volume":"13","author":"Christensen","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"10.1016\/j.ejpb.2023.04.012_b0090","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ijpharm.2017.03.003","article-title":"The diffusion dynamics of PEGylated liposomes in the intact vitreous of the ex vivo porcine eye: a fluorescence correlation spectroscopy and biodistribution study","volume":"522","author":"Eriksen","year":"2017","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.ejpb.2023.04.012_b0095","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1021\/acs.oprd.1c00230","article-title":"Preparative synthesis of an R P-guanosine-3\u2032, 5\u2032-cyclic phosphorothioate analogue, a drug candidate for the treatment of retinal degenerations","volume":"25","author":"P\u00e9rez","year":"2021","journal-title":"Org. Process Res. Dev."},{"key":"10.1016\/j.ejpb.2023.04.012_b0100","doi-asserted-by":"crossref","unstructured":"H. Zhang, Thin-Film Hydration Followed by Extrusion Method for Liposome Preparation, in Liposomes: Methods and Protocols, G.G.M. D'Souza, Editor. 2017, Springer New York: New York, NY. p. 17-22.","DOI":"10.1007\/978-1-4939-6591-5_2"},{"key":"10.1016\/j.ejpb.2023.04.012_b0105","first-page":"259","article-title":"Porcine sclera as a model of human sclera for in vitro transport experiments: histology, SEM, and comparative permeability","volume":"15","author":"Nicoli","year":"2009","journal-title":"Mol. Vis."},{"issue":"1","key":"10.1016\/j.ejpb.2023.04.012_b0110","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jps.24231","article-title":"Development of a convenient ex vivo model for the study of the transcorneal permeation of drugs: histological and permeability evaluation","volume":"104","author":"Pescina","year":"2015","journal-title":"J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2023.04.012_b0115","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ejps.2012.03.013","article-title":"Ex vivo models to evaluate the role of ocular melanin in trans-scleral drug delivery","volume":"46","author":"Pescina","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ejpb.2023.04.012_b0120","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/026119290803600209","article-title":"The automated, accurate and reproducible determination of steady-state permeation parameters from percutaneous permeation data","volume":"36","author":"Niedorf","year":"2008","journal-title":"Altern. Lab. Anim."},{"key":"10.1016\/j.ejpb.2023.04.012_b0125","doi-asserted-by":"crossref","DOI":"10.3791\/61868","article-title":"Long-term, serum-free cultivation of organotypic mouse retina explants with intact retinal pigment epithelium","author":"Belhadj","year":"2020","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ejpb.2023.04.012_b0130","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-1-60327-409-8_1","article-title":"In situ detection of apoptosis by the TUNEL assay: an overview of techniques","volume":"682","author":"Loo","year":"2011","journal-title":"Methods Mol. Biol."},{"issue":"1","key":"10.1016\/j.ejpb.2023.04.012_b0135","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1167\/tvst.9.1.2","article-title":"In vivo measurement of the human vitreous chamber volume using computed tomography imaging of 100 eyes","volume":"9","author":"Azhdam","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"10","key":"10.1016\/j.ejpb.2023.04.012_b0140","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/17425247.2017.1272569","article-title":"How are we improving the delivery to back of the eye? Advances and challenges of novel therapeutic approaches","volume":"14","author":"Agrahari","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2023.04.012_b0145","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jconrel.2014.05.031","article-title":"Nanotherapy for posterior eye diseases","volume":"193","author":"Kaur","year":"2014","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.ejpb.2023.04.012_b0150","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/smll.201303433","article-title":"Topical delivery of Avastin to the posterior segment of the eye in vivo using annexin A5-associated liposomes","volume":"10","author":"Davis","year":"2014","journal-title":"Small"},{"issue":"10","key":"10.1016\/j.ejpb.2023.04.012_b0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-020-02857-1","article-title":"Preparation and evaluation of cubosomes\/cubosomal gels for ocular delivery of beclomethasone dipropionate for management of uveitis","volume":"37","author":"Gaballa","year":"2020","journal-title":"Pharm. Res."},{"issue":"4","key":"10.1016\/j.ejpb.2023.04.012_b0160","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1080\/08982104.2016.1191022","article-title":"Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation","volume":"27","author":"Khalil","year":"2017","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejpb.2023.04.012_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118771","article-title":"Optimization, stabilization, and characterization of amphotericin B loaded nanostructured lipid carriers for ocular drug delivery","volume":"572","author":"Lakhani","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.ejpb.2023.04.012_b0170","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3390\/pharmaceutics13030322","article-title":"Safety and tolerability of topical ophthalmic triamcinolone acetonide-loaded liposomes formulation and evaluation of its biologic activity in patients with diabetic macular edema","volume":"13","author":"Navarro-Partida","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ejpb.2023.04.012_b0175","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3390\/nano9010033","article-title":"In situ gel of triamcinolone acetonide-loaded solid lipid nanoparticles for improved topical ocular delivery: Tear kinetics and ocular disposition studies","volume":"9","author":"Tatke","year":"2018","journal-title":"Nanomaterials"},{"key":"10.1016\/j.ejpb.2023.04.012_b0180","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejps.2018.04.032","article-title":"Biopharmaceutical evaluation of surface active ophthalmic excipients using in vitro and ex vivo corneal models","volume":"120","author":"Jureti\u0107","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2023.04.012_b0185","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejps.2018.03.034","article-title":"Corneal and conjunctival drug permeability: Systematic comparison and pharmacokinetic impact in the eye","volume":"119","author":"Ramsay","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ejpb.2023.04.012_b0190","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ejps.2012.05.007","article-title":"Determination of permeability coefficients of ophthalmic drugs through different layers of porcine, rabbit and bovine eyes","volume":"47","author":"Loch","year":"2012","journal-title":"Eur. J. Pharm. Sci."},{"issue":"8","key":"10.1016\/j.ejpb.2023.04.012_b0195","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1002\/jps.23190","article-title":"Prevalidation of a human cornea construct as an alternative to animal corneas for in vitro drug absorption studies","volume":"101","author":"Hahne","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2023.04.012_b0200","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejps.2018.07.034","article-title":"Esterase activity in porcine and albino rabbit ocular tissues","volume":"123","author":"Heikkinen","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ejpb.2023.04.012_b0205","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1248\/bpb.b13-00059","article-title":"The polyethyleneglycol dilemma: advantage and disadvantage of PEGylation of liposomes for systemic genes and nucleic acids delivery to tumors","volume":"36","author":"Hatakeyama","year":"2013","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejpb.2023.04.012_b0210","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jconrel.2020.10.028","article-title":"Ocular barriers to retinal delivery of intravitreal liposomes: Impact of vitreoretinal interface","volume":"328","author":"Tavakoli","year":"2020","journal-title":"J. Control. Release"},{"issue":"8","key":"10.1016\/j.ejpb.2023.04.012_b0215","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1016\/j.drudis.2019.04.004","article-title":"Recent developments in liposomal drug delivery systems for the treatment of retinal diseases","volume":"24","author":"Urquhart","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"9","key":"10.1016\/j.ejpb.2023.04.012_b0220","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1021\/acs.molpharmaceut.9b00585","article-title":"Distribution of small molecular weight drugs into the porcine lens: studies on imaging mass spectrometry, partition coefficients, and implications in ocular pharmacokinetics","volume":"16","author":"Heikkinen","year":"2019","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.ejpb.2023.04.012_b0225","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1021\/acs.molpharmaceut.6b00864","article-title":"Effective retinal penetration of lipophilic and lipid-conjugated hydrophilic agents delivered by engineered liposomes","volume":"14","author":"Lee","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2023.04.012_b0230","article-title":"Ocular and systemic bio-distribution of rhodamine-conjugated liposomes loaded with VIP injected into the vitreous of Lewis rats","volume":"13","author":"Camelo","year":"2007","journal-title":"Mol. Vis."},{"issue":"2","key":"10.1016\/j.ejpb.2023.04.012_b0235","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-008-9745-6","article-title":"Investigating the movement of intravitreal human serum albumin nanoparticles in the vitreous and retina","volume":"26","author":"Kim","year":"2009","journal-title":"Pharm. Res."},{"issue":"12","key":"10.1016\/j.ejpb.2023.04.012_b0240","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/j.biomaterials.2012.01.030","article-title":"The movement of self-assembled amphiphilic polymeric nanoparticles in the vitreous and retina after intravitreal injection","volume":"33","author":"Koo","year":"2012","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.ejpb.2023.04.012_b0245","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1167\/iovs.02-1068","article-title":"Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles","volume":"44","author":"Bourges","year":"2003","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejpb.2023.04.012_b0250","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"Amo","year":"2017","journal-title":"Prog. Retinal Eye Res."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123000929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641123000929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:41:44Z","timestamp":1777592504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641123000929"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":50,"alternative-id":["S0939641123000929"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.04.012","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ocular permeability, intraocular biodistribution of lipid nanocapsule formulation intended for retinal drug delivery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2023.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}